CN103784552B - Lung benefiting lumor eliminating powder and its production and use - Google Patents
Lung benefiting lumor eliminating powder and its production and use Download PDFInfo
- Publication number
- CN103784552B CN103784552B CN201410054051.2A CN201410054051A CN103784552B CN 103784552 B CN103784552 B CN 103784552B CN 201410054051 A CN201410054051 A CN 201410054051A CN 103784552 B CN103784552 B CN 103784552B
- Authority
- CN
- China
- Prior art keywords
- lung
- powder
- lung benefiting
- eliminating powder
- lumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a kind of lung benefiting lumor eliminating powder and its production and use, product is by Radix Ginseng 50-100 part, Cordyceps 30-100 part, Squama Manis 30-70 part, Radix Notoginseng 25-55 part, Nidus Vespae 150-300 part, Rhizoma Atractylodis Macrocephalae 200-500 part, Herba Hedyotidis Diffusae 100-300 part forms.The present invention has strengthening vital QI to eliminate pathogenic factors, QI invigorating supports lung, the effect of softening the hard mass dispersing tumor; Can effectively treat all kinds pulmonary carcinoma and pulmonary carcinoma is postoperative, after chemicotherapy, without the advanced lung cancer, pulmonary metastasis etc. of surgical indication.
Description
Technical field
The present invention relates to a kind of Chinese powder medicine.
Background technology
It is the fastest that pulmonary carcinoma is that M & M increases, to one of population health and the maximum malignant tumor of life threat.The many countries of immediate and mid-term all report that the M & M of pulmonary carcinoma all obviously increases.Western medical treatment is based on operation, chemicotherapy, targeted therapy, belong to " lethal " treatment, though to a certain degree mitigate the disease, but still there is a lot of not enough and problem, as caused great injury to the body constitution of patient, quality of life obviously declines, and the body and mind increasing patient is painful, easy relapse and metastasis, chemotherapeutic drug resistance etc., and patients with lung cancer is through long-term clinical, medical expense is expensive, is difficult to bear.Therefore, research a kind of " test, letter, just, honest and clean " cancer therapy drug, improve the overall health of patients of patient, improve its life quality, extend life cycle, become one of medical circle urgent problem.
Summary of the invention
The object of the present invention is to provide that a kind of formula is reasonable, evident in efficacy, the lung benefiting lumor eliminating powder of few side effects and uses thereof.
Technical solution of the present invention is:
A kind of lung benefiting lumor eliminating powder, is characterized in that: be the powder be made up of the medicine material of following weight portion: Radix Ginseng 50-100 part, Cordyceps 30-100 part, Squama Manis 30-70 part, Radix Notoginseng 25-55 part, Nidus Vespae 150-300 part, Rhizoma Atractylodis Macrocephalae 200-500 part, Herba Hedyotidis Diffusae 100-300 part.
A kind of preparation method of lung benefiting lumor eliminating powder, it is characterized in that: Nidus Vespae, Rhizoma Atractylodis Macrocephalae, Herba Hedyotidis Diffusae are added water and take extract twice, slow fire concentrates, mix with Radix Ginseng, Cordyceps, Squama Manis, Radix Notoginseng powder, 50 DEG C of oven drying at low temperatures, grind superfine end and cross 120 mesh sieves, encapsulated, 0.3g/ grain, radiosterilization.
A kind of lung benefiting lumor eliminating powder is in preparation treatment pulmonary carcinoma and pulmonary carcinoma is postoperative, after chemicotherapy, without the application in the medicine of the advanced lung cancer of surgical indication, pulmonary metastasis.
The present invention has strengthening vital QI to eliminate pathogenic factors, QI invigorating supports lung, the effect of softening the hard mass dispersing tumor; Can effectively treat all kinds pulmonary carcinoma and pulmonary carcinoma is postoperative, after chemicotherapy, without the advanced lung cancer, pulmonary metastasis etc. of surgical indication.
Model case:
Medical record one, king so-and-so, man, 57 years old, patient's in July, 07 row " left lung cancer resection ", postoperative pathological: left lung large cell carcinoma, postoperatively takes Chinese medicine always.In May, 08, this institute checked CT before going to a doctor: left pulmonary carcinoma Postoperative changes, right lung one dot-hatched.Hectare: left breast is felt oppressed, and gastral cavity abdomen is done swollen, vows that gas is frequent, receive can, just adjust, light red tongue yellow, greasy and thin fur, stringy pulse.This is that pulmonary carcinoma is postoperative, the time of deficiency of both QI and YIN, controls suitable supplementing QI and nourishing YIN, strengthening vital QI to eliminate pathogenic factors, softening hard tissue.Giving relevant tumor decoction of controlling to add lung benefiting lumor eliminating powder and control it.Take medicine 20 doses, uncomfortable in chest showing subtracts, and food of sleeping all is pacified.The bimester of taking medicine, check CT: left pulmonary carcinoma Postoperative changes, middle lobe of right lung lesser tubercle is similar to front.Take medicine half a year, check CT: left pulmonary carcinoma is postoperative, right lung tuberosity shadow is comparatively front similar.Patient's self-induction is bitter without institute, receives fragrant, just adjusts.Adhere to taking lung benefiting lumor eliminating powder, periodic review, stable disease, live as usual.
Medical record two, Lee so-and-so, man, 47 years old, patient in April, 08 is diagnosed as because " left chest pain " checks " the vertical phrenic lymph nodes of upper left lung small cell lung cancer companion shifts ".Do not perform the operation, chemotherapy 9 times, radiotherapy 30 times.Check CT in by the end of October, 08: change after the lung therapy for small cell lung cancer of upper left, inferior lobe of left lung dorsal segment inflammation, left thoracic cavity hydrops.Because blood three is minimizing, stop chemicotherapy.Come this institute in December, 08 to go to a doctor, hemogram at that time: RBC 2.04 × 10
12/ L, Hb 60g/L, WBC 1.65 × 10
9/ L, PLT 46 × 10
9/ L.Hectare: spirit is withered soft, and pale complexion is simple and unadorned, cough, and poor appetite, just adjusts, and the purple white and thin fur of light red tongue, thready and soft pulse is unable.This is that healthy energy is heavy hungry, and deficiency of both QI and blood, aunt gives righting Xiao Disorder method.Giving relevant tumor decoction of controlling to add lung benefiting lumor eliminating powder and control it.Take medicine 20 doses, check routine blood test: WBC 5.1 × 10
9/ L, PLT 164 × 10
9/ L, occasionally cough, spirit is gradually shaken, and complexion is gradually ruddy, receive can, just adjust.Take medicine 40 doses, routine blood test keeps normal, can travel outdoors.The bimester of taking medicine, check breast CT: change after the lung therapy for small cell lung cancer of upper left, inferior lobe of left lung dorsal segment radioactive inflammation.Hemogram: WBC 4.12 × 10
9/ L, RBC3.48 × 10
12/ L, Hb 120g/L, PLT 135 × 10
9/ L.Take medicine October, check chest, cerebral CT show no obvious abnormalities.Patient's self-induction is without discomfort, and spirit is good, has rosy cheeks, receives fragrant, just adjust.Decoction gradually decrement adds lung benefiting lumor eliminating powder and continues to strengthen treatment so far, periodic review, stable disease, from bitter without institute.
Below in conjunction with embodiment, the invention will be further described.
Detailed description of the invention
A kind of lung benefiting lumor eliminating powder, it is the powder be made up of the medicine material of following weight portion: Radix Ginseng 50-100 part (example 50 parts, 70 parts, 100 parts), Cordyceps 30-100 part (example 30 parts, 60 parts, 100 parts), Squama Manis 30-70 part (example 30 parts, 40 parts, 70 parts), Radix Notoginseng 25-55 part (example 25 parts, 40 parts, 55 parts), Nidus Vespae 150-300 part (example 150 parts, 230 parts, 300 parts), Rhizoma Atractylodis Macrocephalae 200-500 part (example 200 parts, 350 parts, 500 parts), Herba Hedyotidis Diffusae 100-300 part (example 100 parts, 200 parts, 300 parts).
Preparation method, is characterized in that: Nidus Vespae, Rhizoma Atractylodis Macrocephalae, Herba Hedyotidis Diffusae are added water and take extract twice, and slow fire concentrates, mix with Radix Ginseng, Cordyceps, Squama Manis, Radix Notoginseng powder, 50 DEG C of oven drying at low temperatures, grind superfine end and cross 120 mesh sieves, encapsulated, 0.3g/ grain, radiosterilization.
A kind of lung benefiting lumor eliminating powder is used for the treatment of pulmonary carcinoma and pulmonary carcinoma is postoperative, after chemicotherapy, without the advanced lung cancer of surgical indication, the medicine of pulmonary metastasis.Usage: oral.A 1.8g, 3 times on the one.
Claims (3)
1. a lung benefiting lumor eliminating powder, is characterized in that: be the powder be made up of the medicine material of following weight portion: Radix Ginseng 50-100 part, Cordyceps 30-100 part, Squama Manis 30-70 part, Radix Notoginseng 25-55 part, Nidus Vespae 150-300 part, Rhizoma Atractylodis Macrocephalae 200-500 part, Herba Hedyotidis Diffusae 100-300 part.
2. the preparation method of a lung benefiting lumor eliminating powder according to claim 1, it is characterized in that: Nidus Vespae, Rhizoma Atractylodis Macrocephalae, Herba Hedyotidis Diffusae are added water and take extract twice, slow fire concentrates, mix with Radix Ginseng, Cordyceps, Squama Manis, Radix Notoginseng powder, 50 DEG C of oven drying at low temperatures, grind superfine end and cross 120 mesh sieves, encapsulated, 0.3g/ grain, radiosterilization.
3. the application of lung benefiting lumor eliminating powder according to claim 1 in the medicine of preparation treatment pulmonary carcinoma.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410054051.2A CN103784552B (en) | 2014-02-18 | 2014-02-18 | Lung benefiting lumor eliminating powder and its production and use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410054051.2A CN103784552B (en) | 2014-02-18 | 2014-02-18 | Lung benefiting lumor eliminating powder and its production and use |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103784552A CN103784552A (en) | 2014-05-14 |
CN103784552B true CN103784552B (en) | 2015-09-09 |
Family
ID=50660889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410054051.2A Active CN103784552B (en) | 2014-02-18 | 2014-02-18 | Lung benefiting lumor eliminating powder and its production and use |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103784552B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1171242A (en) * | 1996-07-19 | 1998-01-28 | 宋树田 | Compound anticancer Chinese medicine |
CN102552856A (en) * | 2012-02-16 | 2012-07-11 | 朱良春 | Powder for strengthening body resistance and eliminating tumor, and preparation method and application thereof |
-
2014
- 2014-02-18 CN CN201410054051.2A patent/CN103784552B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1171242A (en) * | 1996-07-19 | 1998-01-28 | 宋树田 | Compound anticancer Chinese medicine |
CN102552856A (en) * | 2012-02-16 | 2012-07-11 | 朱良春 | Powder for strengthening body resistance and eliminating tumor, and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN103784552A (en) | 2014-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103127482A (en) | Medicine for treating cancer and preparation method thereof | |
CN100593417C (en) | Chinese traditional medicine for treating gastric cancer and bone cancer | |
CN102688317B (en) | Traditional Chinese medicine for treating liver cancer | |
CN104305170A (en) | Traditional Chinese medicine food formula for radiotherapy postoperative rehabilitation and preparation method thereof | |
CN103784552B (en) | Lung benefiting lumor eliminating powder and its production and use | |
CN104352603A (en) | Anti-tumor traditional Chinese medicine capable of enhancing immunity of human body | |
CN107898989A (en) | A kind of Chinese medicine composition for treating obstructive sleep apnea syndrome and preparation method thereof | |
CN103169746A (en) | Traditional Chinese medicine composition for treating lung cancer | |
CN105055929A (en) | Traditional Chinese medicinal preparation for treating lung cancer | |
CN106266972A (en) | A kind of Chinese medicine formula treating pulmonary carcinoma | |
CN101406625B (en) | Chinese medicinal composition for treating cancer as well as preparation method and use thereof | |
CN101549025A (en) | Traditional Chinese medicine for treating cancer | |
CN110368440A (en) | Alleviate the Chinese medicine composition and preparation method thereof of side effect of digestive tract | |
CN104623525A (en) | Traditional Chinese medicine for treating senile dementia | |
CN102114116B (en) | Traditional Chinese medicine for treating esophageal carcinoma | |
CN1202374A (en) | Chinese herbal medicine wine for curing leukamia | |
CN107617077A (en) | A kind of Chinese medicine preparation for treating malignant tumour and preparation method thereof | |
CN101530589B (en) | Chinese medicinal preparation for treating cancers | |
CN106421657B (en) | A kind of Chinese medicine composition for the treatment of cancer pain | |
CN103751670B (en) | The Chinese medicine composition of auxiliary lung cancer chemotherapy | |
CN105998908A (en) | Chinese herba preparation for treating tumors and resisting toxic and side effects of chemotherapy and preparation method thereof | |
CN106333971A (en) | Anti-lung-cancer traditional Chinese medicine composition | |
CN114949140A (en) | Traditional Chinese medicine patch for treating cancer-associated liver-yang deficiency type depression and preparation method thereof | |
CN103977195A (en) | Pharmaceutical composition for treating nasopharynx cancer | |
CN107281420A (en) | Treat the Chinese medicine preparation of lung cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |